PFIZER DAUNORUBICIN daunorubicin (as hydrochloride) 18.7 mg powder for injection vial

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Aktivna sestavina:

daunorubicin hydrochloride, Quantity: 20 mg (Equivalent: daunorubicin, Qty 18.7 mg)

Dostopno od:

Pfizer Australia Pty Ltd

Farmacevtska oblika:

Injection, powder for

Sestava:

Excipient Ingredients: mannitol

Pot uporabe:

Intravenous Infusion

Enote v paketu:

1

Tip zastaranja:

(S4) Prescription Only Medicine

Terapevtske indikacije:

Pfizer Daunorubicin Powder for Injection is indicated for the treatment of the following:,Acute lymphocytic (lymphoblastic) leukaemia,Daunorubicin is usually reserved for use in cases shown to be resistant to other drugs. However, combined treatment with daunorubicin, vincristine and a steroid has been used in the early stages of this disease.,Acute myeloblastic leukaemia,Daunorubicin has been used in all stages, alone or in combination with other cytotoxic agents (e.g., cytarabine).,Disseminated solid tumours,Daunorubicin has been investigated for use in these tumours and found to be effective in some cases of disseminated neuroblastoma and rhabdomyosarcoma.

Povzetek izdelek:

Visual Identification: Colourless glass vials containing a porous, red-orange freeze-dried cake or mass; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Status dovoljenje:

Registered

Datum dovoljenje:

2023-09-01